HIV and HIV treatment: effects on fats, glucose and lipids

被引:14
作者
Gkrania-Klotsas, Effrossyni [1 ]
Klotsas, Angelos-Emmanouil [2 ]
机构
[1] Addenbrookes Hosp, Dept Infect Dis, Cambridge CB22QQ, England
[2] Ipswich Hosp NHS Trust, Dept Endocrinol & Diabet, Ipswich, Suffolk, England
关键词
HIV; HAART; lipodystrophy; lipoatrophy; lipohypertrophy; hyperlipidemia; diabetes mellitus; insulin resistance; metabolism;
D O I
10.1093/bmb/ldm030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Since the advent of effective antiretroviral therapy, infection with the human immunodeficiency virus has been transformed, in the Western world, to a chronic disease associated with a variety of metabolic complications. Aims: This review provides a brief summary of our current understanding of the epidemiology, clinical presentation and therapeutic approaches of what is termed 'the HIV-associated lipodystrophy syndrome' and of HIV-associated lipid and glucose metabolic abnormalities. Other metabolic associations including lactic acidosis, HIV-associated bone disease and the effect of the virus on other endocrine pathways are outside the scope of this article. Methods: A bibliographic search was performed using Entrez Pubmed (R), edition 2.0, by the National Library of Medicine for articles only in the English language using Boolean operators and the terms 'HIV, HAART, lipodystrophy, lipoatrophy, lipohypertrophy, hyperlipidemia, diabetes and metabolism, cost of illness'. The Program and Abstract Books of the 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (September 24-26, 2006, San Francisco, USA), the 4th International AIDS Society Conference on HIV Pathogenesis (July 22-25, 2007, Sydney Australia) and the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (September 17-20, Chicago, USA) were searched for relative abstracts. Previous publications were used to identify further references. Approximately 1400 articles and abstracts were identified of which 104 were selected for review. Results: Specific medications and medication classes increase the lipoatrophy and lipodystrophy risk. A change of treatment strategy might be beneficial in improving adipose tissue deposition. The effects of HIV on metabolism offer new insights into cardiovascular disease pathogenesis.
引用
收藏
页码:49 / 68
页数:20
相关论文
共 108 条
[1]   Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study [J].
Andersen, O ;
Haugaard, SB ;
Flyvbjerg, A ;
Andersen, UB ;
Orskov, H ;
Madsbad, S ;
Nielsen, JO ;
Iversen, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (08) :561-568
[3]  
[Anonymous], AIDS READER
[4]   Fat distribution in men with HIV infection [J].
Bacchetti, P ;
Gripshover, B ;
Grunfeld, C ;
Heymsfield, S ;
McCreath, H ;
Osmond, D ;
Saag, M ;
Scherzer, R ;
Shlipak, M ;
Tien, P .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) :121-131
[5]   Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].
Behrens, G ;
Dejam, A ;
Schmidt, H ;
Balks, HJ ;
Brabant, G ;
Körner, T ;
Stoll, M ;
Schmidt, RE .
AIDS, 1999, 13 (10) :F63-F70
[6]   Agreement analysis of variables involved in lipodystrophy syndrome definition in HIV-infected patients [J].
Belloso, WH ;
Quirós, RE ;
Ivalo, SA ;
Perman, MI ;
Galich, AM ;
Stern, LD ;
Barcán, LA .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (01) :104-111
[7]   Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV [J].
Bennett, Matthew T. ;
Johns, Kevin W. ;
Bondy, Gregory P. .
LIPIDS IN HEALTH AND DISEASE, 2007, 6 (1)
[8]   Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals [J].
Brambilla, AM ;
Novati, R ;
Calori, G ;
Meneghini, E ;
Vacchini, D ;
Luzi, L ;
Castagna, A ;
Lazzarin, A .
AIDS, 2003, 17 (13) :1993-1995
[9]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[10]  
CAHN PE, 2004, J INT ASS PHYS AIDS, V33, P92